366 related articles for article (PubMed ID: 26208678)
1. Hepatitis B and A vaccination in HIV-infected adults: A review.
Mena G; García-Basteiro AL; Bayas JM
Hum Vaccin Immunother; 2015; 11(11):2582-98. PubMed ID: 26208678
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity, effectiveness and safety of combined hepatitis A and B vaccine: a systematic literature review.
Bakker M; Bunge EM; Marano C; de Ridder M; De Moerlooze L
Expert Rev Vaccines; 2016 Jul; 15(7):829-51. PubMed ID: 26840060
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis A vaccine response in HIV-infected patients: are TWINRIX and HAVRIX interchangeable?
Jimenez HR; Hallit RR; Debari VA; Slim J
Vaccine; 2013 Feb; 31(9):1328-33. PubMed ID: 23277097
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.
Gilca V; Sauvageau C; Boulianne N; De Serres G; Couillard M; Krajden M; Ouakki M; Murphy D; Trevisan A; Dionne M
Hum Vaccin Immunother; 2014; 10(8):2438-45. PubMed ID: 25424952
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.
Rey D; Piroth L; Wendling MJ; Miailhes P; Michel ML; Dufour C; Haour G; Sogni P; Rohel A; Ajana F; Billaud E; Molina JM; Launay O; Carrat F;
Lancet Infect Dis; 2015 Nov; 15(11):1283-91. PubMed ID: 26257021
[TBL] [Abstract][Full Text] [Related]
7. Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease.
Shapiro AJ; Esther CR; Leigh MW; Dellon EP
Vaccine; 2013 Jan; 31(6):906-11. PubMed ID: 23261047
[TBL] [Abstract][Full Text] [Related]
8. Predictors of humoral response to recommended vaccines in HIV-infected adults.
Tsachouridou O; Christaki E; Skoura L; Georgiou A; Nanoudis S; Vasdeki D; Ntziovara MA; Kotoreni G; Forozidou E; Tsoukra P; Germanidis G; Metallidis S
Comp Immunol Microbiol Infect Dis; 2017 Oct; 54():27-33. PubMed ID: 28915998
[TBL] [Abstract][Full Text] [Related]
9. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy.
Lao-Araya M; Puthanakit T; Aurpibul L; Taecharoenkul S; Sirisanthana T; Sirisanthana V
Vaccine; 2011 May; 29(23):3977-81. PubMed ID: 21473954
[TBL] [Abstract][Full Text] [Related]
11. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
Van Damme P; Van Herck K
Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
[TBL] [Abstract][Full Text] [Related]
12. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
[TBL] [Abstract][Full Text] [Related]
13. Vaccination against viral hepatitis of HIV-1 infected patients.
Phung BC; Launay O
Hum Vaccin Immunother; 2012 May; 8(5):554-9. PubMed ID: 22634451
[TBL] [Abstract][Full Text] [Related]
14. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
[TBL] [Abstract][Full Text] [Related]
17. Long-term response rates of successful hepatitis B vaccination in HIV-infected patients.
Lopes VB; Hassing RJ; de Vries-Sluijs TE; El Barzouhi A; Hansen BE; Schutten M; de Man RA; van der Ende ME
Vaccine; 2013 Feb; 31(7):1040-4. PubMed ID: 23273969
[TBL] [Abstract][Full Text] [Related]
18. Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults.
Potsch DV; Camacho LA; Tuboi S; Villar LM; Miguel JC; Ginuíno C; Silva EF; Mendonça RM; Moreira RB; Barroso PF
Vaccine; 2012 Sep; 30(41):5973-7. PubMed ID: 22828589
[TBL] [Abstract][Full Text] [Related]
19. Antibody persistence and immune memory 4 years post-vaccination with combined hepatitis A and B vaccine in adults aged over 40 years.
Chlibek R; von Sonnenburg F; Van Damme P; Smetana J; Tichy P; Gunapalaiah B; Leyssen M; Jacquet JM
J Travel Med; 2011; 18(2):145-8. PubMed ID: 21366801
[TBL] [Abstract][Full Text] [Related]
20. Experience with hepatitis A and B vaccines.
Davis JP
Am J Med; 2005 Oct; 118 Suppl 10A():7S-15S. PubMed ID: 16271535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]